Ethnic and gender differences in rates of congenital adrenal hyperplasia in Western Australia over a 21 year period

Aim:  To evaluate the incidence, sex distribution, ethnicity, age at diagnosis, clinical presentation and morbidity of all childhood‐onset congenital adrenal hyperplasia (CAH) cases in Western Australia (WA) between 1990 and 2010, a state where newborn screening for CAH is not in place. Methods:  Th...

Full description

Saved in:
Bibliographic Details
Published inJournal of paediatrics and child health Vol. 48; no. 11; pp. 1029 - 1032
Main Authors Shetty, Vinutha B, Bower, Carol, Jones, Timothy W, Lewis, Barry D, Davis, Elizabeth A
Format Journal Article
LanguageEnglish
Published Melbourne, Australia Blackwell Publishing Asia 01.11.2012
Blackwell Publishing Ltd
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Aim:  To evaluate the incidence, sex distribution, ethnicity, age at diagnosis, clinical presentation and morbidity of all childhood‐onset congenital adrenal hyperplasia (CAH) cases in Western Australia (WA) between 1990 and 2010, a state where newborn screening for CAH is not in place. Methods:  The total number of all known CAH cases was identified. Case files were reviewed retrospectively to determine clinical details. Classical CAH (C‐CAH) was defined as patients presenting before 6 months of age and non‐classical (NC‐CAH) as presenting after 6 months. Results:  Of the 41 CAH cases (26 female) born in WA, 5(12.2%) were of Aboriginal ethnicity. CAH was due to 21‐hydroxylase deficiency in 40 cases. Of those with 21‐hydroxylase deficiency, 37 were C‐CAH (25 female) and 3 NC‐CAH (all male). The incidence of C‐CAH in WA was estimated to be 0.67 per 10 000 live births (1:14 869). The incidence rate ratio of Aboriginal compared with non‐Aboriginal C‐CAH was 2.45 (95% confidence interval 0.96–6.29). The mean age of diagnosis of C‐CAH cases was lower in females (8.9 ± 2.5 days) compared to males (23.4 ± 9.8 days). Among these males, 72.7% presented initially with adrenal crisis. Conclusion:  The estimated incidence of classical CAH is similar to composite worldwide data. The increased female‐to‐male ratio is not in keeping with the expected sex distribution seen in a recessively inherited disease. The delayed diagnosis in males, with a significant proportion presenting with adrenal crisis, could be avoided with newborn screening. The higher rate of CAH in patients with Aboriginal ethnicity is a novel observation.
AbstractList AIMTo evaluate the incidence, sex distribution, ethnicity, age at diagnosis, clinical presentation and morbidity of all childhood-onset congenital adrenal hyperplasia (CAH) cases in Western Australia (WA) between 1990 and 2010, a state where newborn screening for CAH is not in place.METHODSThe total number of all known CAH cases was identified. Case files were reviewed retrospectively to determine clinical details. Classical CAH (C-CAH) was defined as patients presenting before 6 months of age and non-classical (NC-CAH) as presenting after 6 months.RESULTSOf the 41 CAH cases (26 female) born in WA, 5(12.2%) were of Aboriginal ethnicity. CAH was due to 21-hydroxylase deficiency in 40 cases. Of those with 21-hydroxylase deficiency, 37 were C-CAH (25 female) and 3 NC-CAH (all male). The incidence of C-CAH in WA was estimated to be 0.67 per 10, 000 live births (1:14, 869). The incidence rate ratio of Aboriginal compared with non-Aboriginal C-CAH was 2.45 (95% confidence interval 0.96-6.29). The mean age of diagnosis of C-CAH cases was lower in females (8.9 ± 2.5 days) compared to males (23.4 ± 9.8 days). Among these males, 72.7% presented initially with adrenal crisis.CONCLUSIONThe estimated incidence of classical CAH is similar to composite worldwide data. The increased female-to-male ratio is not in keeping with the expected sex distribution seen in a recessively inherited disease. The delayed diagnosis in males, with a significant proportion presenting with adrenal crisis, could be avoided with newborn screening. The higher rate of CAH in patients with Aboriginal ethnicity is a novel observation.
Aim:  To evaluate the incidence, sex distribution, ethnicity, age at diagnosis, clinical presentation and morbidity of all childhood‐onset congenital adrenal hyperplasia (CAH) cases in Western Australia (WA) between 1990 and 2010, a state where newborn screening for CAH is not in place. Methods:  The total number of all known CAH cases was identified. Case files were reviewed retrospectively to determine clinical details. Classical CAH (C‐CAH) was defined as patients presenting before 6 months of age and non‐classical (NC‐CAH) as presenting after 6 months. Results:  Of the 41 CAH cases (26 female) born in WA, 5(12.2%) were of Aboriginal ethnicity. CAH was due to 21‐hydroxylase deficiency in 40 cases. Of those with 21‐hydroxylase deficiency, 37 were C‐CAH (25 female) and 3 NC‐CAH (all male). The incidence of C‐CAH in WA was estimated to be 0.67 per 10 000 live births (1:14 869). The incidence rate ratio of Aboriginal compared with non‐Aboriginal C‐CAH was 2.45 (95% confidence interval 0.96–6.29). The mean age of diagnosis of C‐CAH cases was lower in females (8.9 ± 2.5 days) compared to males (23.4 ± 9.8 days). Among these males, 72.7% presented initially with adrenal crisis. Conclusion:  The estimated incidence of classical CAH is similar to composite worldwide data. The increased female‐to‐male ratio is not in keeping with the expected sex distribution seen in a recessively inherited disease. The delayed diagnosis in males, with a significant proportion presenting with adrenal crisis, could be avoided with newborn screening. The higher rate of CAH in patients with Aboriginal ethnicity is a novel observation.
Aim:  To evaluate the incidence, sex distribution, ethnicity, age at diagnosis, clinical presentation and morbidity of all childhood‐onset congenital adrenal hyperplasia (CAH) cases in Western Australia (WA) between 1990 and 2010, a state where newborn screening for CAH is not in place. Methods:  The total number of all known CAH cases was identified. Case files were reviewed retrospectively to determine clinical details. Classical CAH (C‐CAH) was defined as patients presenting before 6 months of age and non‐classical (NC‐CAH) as presenting after 6 months. Results:  Of the 41 CAH cases (26 female) born in WA, 5(12.2%) were of Aboriginal ethnicity. CAH was due to 21‐hydroxylase deficiency in 40 cases. Of those with 21‐hydroxylase deficiency, 37 were C‐CAH (25 female) and 3 NC‐CAH (all male). The incidence of C‐CAH in WA was estimated to be 0.67 per 10 000 live births (1:14 869). The incidence rate ratio of Aboriginal compared with non‐Aboriginal C‐CAH was 2.45 (95% confidence interval 0.96–6.29). The mean age of diagnosis of C‐CAH cases was lower in females (8.9 ± 2.5 days) compared to males (23.4 ± 9.8 days). Among these males, 72.7% presented initially with adrenal crisis. Conclusion:  The estimated incidence of classical CAH is similar to composite worldwide data. The increased female‐to‐male ratio is not in keeping with the expected sex distribution seen in a recessively inherited disease. The delayed diagnosis in males, with a significant proportion presenting with adrenal crisis, could be avoided with newborn screening. The higher rate of CAH in patients with Aboriginal ethnicity is a novel observation.
Aim: To evaluate the incidence, sex distribution, ethnicity, age at diagnosis, clinical presentation and morbidity of all childhood-onset congenital adrenal hyperplasia (CAH) cases in Western Australia (WA) between 1990 and 2010, a state where newborn screening for CAH is not in place. Methods: The total number of all known CAH cases was identified. Case files were reviewed retrospectively to determine clinical details. Classical CAH (C-CAH) was defined as patients presenting before 6months of age and non-classical (NC-CAH) as presenting after 6months. Results: Of the 41 CAH cases (26 female) born in WA, 5(12.2%) were of Aboriginal ethnicity. CAH was due to 21-hydroxylase deficiency in 40 cases. Of those with 21-hydroxylase deficiency, 37 were C-CAH (25 female) and 3 NC-CAH (all male). The incidence of C-CAH in WA was estimated to be 0.67 per 10000 live births (1:14869). The incidence rate ratio of Aboriginal compared with non-Aboriginal C-CAH was 2.45 (95% confidence interval 0.96-6.29). The mean age of diagnosis of C-CAH cases was lower in females (8.9±2.5days) compared to males (23.4±9.8days). Among these males, 72.7% presented initially with adrenal crisis. Conclusion: The estimated incidence of classical CAH is similar to composite worldwide data. The increased female-to-male ratio is not in keeping with the expected sex distribution seen in a recessively inherited disease. The delayed diagnosis in males, with a significant proportion presenting with adrenal crisis, could be avoided with newborn screening. The higher rate of CAH in patients with Aboriginal ethnicity is a novel observation. [PUBLICATION ABSTRACT]
To evaluate the incidence, sex distribution, ethnicity, age at diagnosis, clinical presentation and morbidity of all childhood-onset congenital adrenal hyperplasia (CAH) cases in Western Australia (WA) between 1990 and 2010, a state where newborn screening for CAH is not in place. The total number of all known CAH cases was identified. Case files were reviewed retrospectively to determine clinical details. Classical CAH (C-CAH) was defined as patients presenting before 6 months of age and non-classical (NC-CAH) as presenting after 6 months. Of the 41 CAH cases (26 female) born in WA, 5(12.2%) were of Aboriginal ethnicity. CAH was due to 21-hydroxylase deficiency in 40 cases. Of those with 21-hydroxylase deficiency, 37 were C-CAH (25 female) and 3 NC-CAH (all male). The incidence of C-CAH in WA was estimated to be 0.67 per 10, 000 live births (1:14, 869). The incidence rate ratio of Aboriginal compared with non-Aboriginal C-CAH was 2.45 (95% confidence interval 0.96-6.29). The mean age of diagnosis of C-CAH cases was lower in females (8.9 ± 2.5 days) compared to males (23.4 ± 9.8 days). Among these males, 72.7% presented initially with adrenal crisis. The estimated incidence of classical CAH is similar to composite worldwide data. The increased female-to-male ratio is not in keeping with the expected sex distribution seen in a recessively inherited disease. The delayed diagnosis in males, with a significant proportion presenting with adrenal crisis, could be avoided with newborn screening. The higher rate of CAH in patients with Aboriginal ethnicity is a novel observation.
Author Shetty, Vinutha B
Jones, Timothy W
Davis, Elizabeth A
Bower, Carol
Lewis, Barry D
Author_xml – sequence: 1
  givenname: Vinutha B
  surname: Shetty
  fullname: Shetty, Vinutha B
  organization: Department of Endocrinology
– sequence: 2
  givenname: Carol
  surname: Bower
  fullname: Bower, Carol
  organization: Western Australian Register of Developmental Anomalies, King Edward Memorial Hospital
– sequence: 3
  givenname: Timothy W
  surname: Jones
  fullname: Jones, Timothy W
  organization: Department of Endocrinology
– sequence: 4
  givenname: Barry D
  surname: Lewis
  fullname: Lewis, Barry D
  organization: Department of Clinical Biochemistry, Path West Laboratory Medicine, Princess Margaret Hospital for Children
– sequence: 5
  givenname: Elizabeth A
  surname: Davis
  fullname: Davis, Elizabeth A
  email: Elizabeth.Davis@health.wa.gov.au
  organization: Department of Endocrinology
BackLink https://www.ncbi.nlm.nih.gov/pubmed/23039988$$D View this record in MEDLINE/PubMed
BookMark eNqNkU1v1DAQhi1URD_gLyBLXLgk-CuJc-BQVqUFqoJE0R4tJ55QL1lnsRPY_fedsO0eONWXGXmedzzj95QchSEAIZSznON5t8q5UizjVaFywbjImSi0yrfPyMmhcIQ5kypTmrNjcprSijHECv2CHAvJZF1rfULSxXgXfEttcPQnBAeROt91ECG0kKgPNNoRk6Gj7RCQ8KPtqXVYx3i320Dc9DZ5O6NLSCPEQM-nNEbb4-XwBxtaKjjdgY0UaT-4l-R5Z_sErx7iGfnx8eJ2cZVdf738tDi_zlpVKhxcWl455rQrKq063rGmVLKBsmmFBCsUkwV0oJQuZcPKhnPNrNCVqkruBO5-Rt7u-27i8HvC2czapxb63gYYpmQ4V7yQuhAlom_-Q1fDFHHFmZJCl7WSc0O9p9o4pBShM5vo1zbuDGdmNsaszPz_Zv5_Mxtj_hljtih9_fDA1KzBHYSPTiDwfg_89T3sntzYfP62mDPUZ3u9Rw-2B72Nv0xZyaowy5tL8_12WV99KL6YWt4DIBmrgg
CitedBy_id crossref_primary_10_1155_2016_5748264
crossref_primary_10_1177_1099800413486340
crossref_primary_10_1016_j_ymgmr_2016_02_005
crossref_primary_10_52727_2078_256X_2022_18_4_426_429
crossref_primary_10_1515_jpem_2020_0681
crossref_primary_10_3389_fped_2021_659492
crossref_primary_10_5694_mja14_00402
crossref_primary_10_1210_jc_2018_01865
crossref_primary_10_1159_000526401
crossref_primary_10_3389_fendo_2023_1102741
crossref_primary_10_1210_endrev_bnab016
crossref_primary_10_1210_jendso_bvz013
crossref_primary_10_1210_jc_2014_3168
Cites_doi 10.1001/archpedi.153.12.1272
10.1542/peds.108.6.1320
10.1007/s00431-003-1311-y
10.1007/s10024-005-0004-0
10.1542/peds.101.4.583
10.1542/peds.101.4.e11
10.1159/000098400
10.1111/j.1440-1754.2008.01383.x
10.1007/s00431-006-0154-8
10.1210/jc.78.2.241
10.1136/adc.70.3.214
10.1515/JPEM.2008.21.5.455
10.1016/S0022-3476(95)70513-9
10.1159/000113023
10.1515/JPEM.2009.22.2.127
10.1016/S0959-8049(03)00152-7
10.1210/jc.2006-0964
10.1210/jc.2002-012093
10.1210/jc.86.7.2958
10.1177/088307389100600404
10.1016/S0929-6646(10)60035-6
10.1159/000082896
10.1159/000110586
10.1590/S0043-31442006000200009
ContentType Journal Article
Copyright 2012 The Authors. Journal of Paediatrics and Child Health © 2012 Paediatrics and Child Health Division (Royal Australasian College of Physicians)
2012 The Authors. Journal of Paediatrics and Child Health © 2012 Paediatrics and Child Health Division (Royal Australasian College of Physicians).
Journal of Paediatrics and Child Health © 2012 Paediatrics and Child Health Division (Royal Australasian College of Physicians)
Copyright_xml – notice: 2012 The Authors. Journal of Paediatrics and Child Health © 2012 Paediatrics and Child Health Division (Royal Australasian College of Physicians)
– notice: 2012 The Authors. Journal of Paediatrics and Child Health © 2012 Paediatrics and Child Health Division (Royal Australasian College of Physicians).
– notice: Journal of Paediatrics and Child Health © 2012 Paediatrics and Child Health Division (Royal Australasian College of Physicians)
DBID BSCLL
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
ASE
FPQ
K6X
K9.
NAPCQ
7X8
DOI 10.1111/j.1440-1754.2012.02584.x
DatabaseName Istex
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
British Nursing Index
British Nursing Index (BNI) (1985 to Present)
British Nursing Index
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
British Nursing Index
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

CrossRef
ProQuest Health & Medical Complete (Alumni)
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1440-1754
EndPage 1032
ExternalDocumentID 2807544041
10_1111_j_1440_1754_2012_02584_x
23039988
JPC2584
ark_67375_WNG_STW9HB5K_9
Genre article
Journal Article
Feature
GeographicLocations Western Australia
Western Australia Australia
GeographicLocations_xml – name: Western Australia
– name: Western Australia Australia
GroupedDBID ---
.3N
.GA
.GJ
.Y3
05W
0R~
10A
1OB
1OC
29L
31~
33P
36B
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AANLZ
AAONW
AASGY
AAVGM
AAWTL
AAXRX
AAZKR
ABCQN
ABCUV
ABEML
ABHUG
ABIVO
ABJNI
ABPTK
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFS
ACGOF
ACMXC
ACPOU
ACSCC
ACXBN
ACXME
ACXQS
ADAWD
ADBBV
ADBTR
ADDAD
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFEBI
AFFPM
AFGKR
AFPWT
AFVGU
AFZJQ
AGJLS
AHBTC
AHEFC
AHMBA
AIACR
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ATUGU
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BSCLL
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
DUUFO
EBS
EJD
EMOBN
ESX
EX3
F00
F01
F04
F5P
FEDTE
FUBAC
FZ0
G-S
G.N
GODZA
H.X
HF~
HVGLF
HZI
HZ~
IHE
IX1
J0M
K48
KBYEO
KTM
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
R.K
RIWAO
RJQFR
ROL
RX1
SAMSI
SUPJJ
TEORI
UB1
W8V
W99
WBKPD
WH7
WHWMO
WIH
WIJ
WIK
WOHZO
WOQ
WOW
WQJ
WRC
WUP
WVDHM
WXI
WXSBR
XG1
YFH
ZGI
ZXP
ZZTAW
~IA
~WT
AITYG
HGLYW
OIG
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
ASE
FPQ
K6X
K9.
NAPCQ
7X8
ID FETCH-LOGICAL-c4644-43a17d0d8d5784f1f0b643be6bc23ea24035efe44863b06b1180a2874761d2103
IEDL.DBID DR2
ISSN 1034-4810
IngestDate Fri Aug 16 10:56:45 EDT 2024
Fri Sep 13 06:53:37 EDT 2024
Fri Aug 23 00:41:38 EDT 2024
Sat Sep 28 08:06:55 EDT 2024
Sat Aug 24 00:54:35 EDT 2024
Wed Jan 17 05:09:09 EST 2024
IsPeerReviewed true
IsScholarly true
Issue 11
Language English
License 2012 The Authors. Journal of Paediatrics and Child Health © 2012 Paediatrics and Child Health Division (Royal Australasian College of Physicians).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4644-43a17d0d8d5784f1f0b643be6bc23ea24035efe44863b06b1180a2874761d2103
Notes ArticleID:JPC2584
ark:/67375/WNG-STW9HB5K-9
istex:9CA42CE2D5325ABBA1497A49B63F2DEAF465E26C
Conflict of interest: None declared.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 23039988
PQID 1132869430
PQPubID 49064
PageCount 4
ParticipantIDs proquest_miscellaneous_1141538526
proquest_journals_1132869430
crossref_primary_10_1111_j_1440_1754_2012_02584_x
pubmed_primary_23039988
wiley_primary_10_1111_j_1440_1754_2012_02584_x_JPC2584
istex_primary_ark_67375_WNG_STW9HB5K_9
PublicationCentury 2000
PublicationDate November 2012
PublicationDateYYYYMMDD 2012-11-01
PublicationDate_xml – month: 11
  year: 2012
  text: November 2012
PublicationDecade 2010
PublicationPlace Melbourne, Australia
PublicationPlace_xml – name: Melbourne, Australia
– name: Australia
– name: Oxford
PublicationTitle Journal of paediatrics and child health
PublicationTitleAlternate J Paediatr Child Health
PublicationYear 2012
Publisher Blackwell Publishing Asia
Blackwell Publishing Ltd
Publisher_xml – name: Blackwell Publishing Asia
– name: Blackwell Publishing Ltd
References Lee C-T, Tung Y-C, Hsiao P-H, Lee J-S, Tsai W-Y. Clinical characteristics of Taiwanese children with congenital adrenal hyperplasia caused by 21-hydroxylase deficiency in the pre-screening era. J. Formos. Med. Assoc. 2010; 109: 148-55.
Nass R, Baker S. Learning disabilities in children with congenital adrenal hyperplasia. J. Child Neurol. 1991; 6: 306-12.
Grosse SD, Van Vliet G. How many deaths can be prevented by newborn screening for congenital adrenal hyperplasia? Horm. Res. 2007; 67: 284-91.
Pang SY, Wallace MA, Hofman L et al. Worldwide experience in newborn screening for classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Pediatrics 1988; 81: 866-74.
Brosnan PG, Brosnan CA, Kemp SF et al. Effect of newborn screening for congenital adrenal hyperplasia. Arch. Pediatr. Adolesc. Med. 1999; 153: 1272-8.
Nimkarn S, Lin-Su K, Berglind N, Wilson RC, New MI. Aldosterone-to-renin ratio as a marker for disease severity in 21-hydroxylase deficiency congenital adrenal hyperplasia. J. Clin. Endocrinol. Metab. 2007; 92: 137-42.
Nordenstrom A, Ahmed S, Jones J et al. Female preponderance in congenital adrenal hyperplasia due to CYP21 deficiency in England: implications for neonatal screening. Horm. Res. 2005; 63: 22-8.
Van der Kamp HJ, Noordam K, Elvers B, Van Baarle M, Otten BJ, Verkerk PH. Newborn screening for congenital adrenal hyperplasia in the Netherlands. Pediatrics 2001; 108: 1320-4.
Dittrich C, Sevelda P, Salzer H et al. Lack of impact of platinum dose intensity on the outcome of ovarian cancer patients. 10-year results of a prospective randomised phase III study comparing carboplatin-cisplatin with cyclophosphamide-cisplatin. Eur. J. Cancer 2003; 39: 1129-40.
Peter S, McDigean G, Sandiford P, Smith T. Congenital adrenal hyperplasia in the Bahamas due to 21-hydroxylase deficiency. West Indian Med. J. 2006; 55: 110-12.
Steigert M, Schoenle EJ, Biason-Lauber A, Torresani T. High reliability of neonatal screening for congenital adrenal hyperplasia in Switzerland. J. Clin. Endocrinol. Metab. 2002; 87: 4106-10.
Balsamo A, Cacciari E, Piazzi S et al. Congenital adrenal hyperplasia: neonatal mass screening compared with clinical diagnosis only in the Emilia-Romagna region of Italy, 1980-1995. Pediatrics 1996; 98: 362-7.
Jeske YWA, McGown IN, Harris M et al. 21-hydroxylase genotyping in Australasian patients with congenital adrenal hyperplasia. J. Pediatr. Endocrinol. 2009; 22: 127-41.
Prader A. [Perfect male external genital development and salt-loss syndrome in girls with congenital adrenogenital syndrome.]. Helv. Paediatr. Acta 1958; 13: 5-14.
Speiser PW. Prenatal and neonatal diagnosis and treatment of congenital adrenal hyperplasia. Horm. Res. 2007; 68 (Suppl. 5): 90-2.
Gleeson HK, Wiley V, Wilcken B et al. Two-year pilot study of newborn screening for congenital adrenal hyperplasia in New South Wales compared with nationwide case surveillance in Australia. J. Paediatr. Child Health 2008; 44: 554-9.
Therrell BL Jr, Berenbaum SA, Manter-Kapanke V et al. Results of screening 1.9 million Texas newborns for 21-hydroxylase-deficient congenital adrenal hyperplasia. Pediatrics 1998; 101: 583-90.
Strnadova KA, Votava F, Lebl J et al. Prevalence of congenital adrenal hyperplasia among sudden infant death in the Czech Republic and Austria. Eur. J. Pediatr. 2007; 166: 1-4.
Liivak K, Tobi S, Schlecht H, Tillmann V. Incidence of classical 21-hydroxylase deficiency and distribution of CYP21A2 mutations in Estonia. Horm. Res. 2008; 69: 227-32.
Cutfield WS, Webster D. Newborn screening for congenital adrenal hyperplasia in New Zealand. J. Pediatr. 1995; 126: 118-21.
Torok D, Eckhardt G, Solyom J. Twenty years experience in rapid identification of congenital adrenal hyperplasia in Hungary. Eur. J. Pediatr. 2003; 162: 844-9.
Kovacs J, Votava F, Heinze G et al. Lessons from 30 years of clinical diagnosis and treatment of congenital adrenal hyperplasia in five middle European countries. J. Clin. Endocrinol. Metab. 2001; 86: 2958-64.
Miller WL. Clinical review 54: genetics, diagnosis, and management of 21-hydroxylase deficiency. J. Clin. Endocrinol. Metab. 1994; 78: 241-6.
Silveira EL, dos Santos EP, Bachega TAS, van der Linden Nader I, Gross JL, Elnecave RH. The actual incidence of congenital adrenal hyperplasia in Brazil may not be as high as inferred - an estimate based on a public neonatal screening program in the state of Goias. J. Pediatr. Endocrinol. 2008; 21: 455-60.
Bhaskaran S, Nair V, Kumar H, Jayakumar RV. Audit of care of patients with congenital adrenal hyperplasia due to 21-Hydroxylase deficiency in a referral hospital in South India. Indian Pediatr. 2006; 43: 419-23.
Thil'en A, Nordenstrom A, Hagenfeldt L, von Dobeln U, Guthenberg C, Larsson A. Benefits of neonatal screening for congenital adrenal hyperplasia (21-hydroxylase deficiency) in Sweden. Pediatrics 1998; 101: E11.
Gozzi TG, Harris NP, McGown IN et al. Autopsy diagnosis of 21-hydroxylase deficiency CAH in a case of apparent SIDS. Pediatr. Dev. Pathol. 2005; 8: 397-401.
Donaldson MD, Thomas PH, Love JG, Murray GD, McNinch AW, Savage DC. Presentation, acute illness, and learning difficulties in salt wasting 21-hydroxylase deficiency. Arch. Dis. Child. 1994; 70: 214-18.
2009; 22
2010; 109
2006; 55
1958; 13
2007; 166
2005; 63
2007; 92
2003; 39
2001; 108
1996; 98
2001; 86
1991; 6
2006; 43
2005; 8
2002; 87
2003; 162
2008; 69
1999; 153
1994; 78
1995; 126
2008; 21
2008; 44
1994; 70
1988; 81
1998; 101
2007; 67
2007; 68
e_1_2_5_26_2
e_1_2_5_27_2
e_1_2_5_24_2
e_1_2_5_25_2
e_1_2_5_22_2
e_1_2_5_23_2
e_1_2_5_20_2
e_1_2_5_21_2
Bhaskaran S (e_1_2_5_14_2) 2006; 43
e_1_2_5_28_2
e_1_2_5_29_2
Pang SY (e_1_2_5_3_2) 1988; 81
e_1_2_5_13_2
e_1_2_5_9_2
e_1_2_5_16_2
e_1_2_5_8_2
e_1_2_5_15_2
Balsamo A (e_1_2_5_4_2) 1996; 98
e_1_2_5_7_2
e_1_2_5_10_2
e_1_2_5_6_2
e_1_2_5_5_2
e_1_2_5_11_2
e_1_2_5_2_2
e_1_2_5_18_2
e_1_2_5_17_2
e_1_2_5_19_2
Prader A (e_1_2_5_12_2) 1958; 13
References_xml – volume: 21
  start-page: 455
  year: 2008
  end-page: 60
  article-title: The actual incidence of congenital adrenal hyperplasia in Brazil may not be as high as inferred – an estimate based on a public neonatal screening program in the state of Goias
  publication-title: J. Pediatr. Endocrinol.
– volume: 81
  start-page: 866
  year: 1988
  end-page: 74
  article-title: Worldwide experience in newborn screening for classical congenital adrenal hyperplasia due to 21‐hydroxylase deficiency
  publication-title: Pediatrics
– volume: 162
  start-page: 844
  year: 2003
  end-page: 9
  article-title: Twenty years experience in rapid identification of congenital adrenal hyperplasia in Hungary
  publication-title: Eur. J. Pediatr.
– volume: 69
  start-page: 227
  year: 2008
  end-page: 32
  article-title: Incidence of classical 21‐hydroxylase deficiency and distribution of CYP21A2 mutations in Estonia
  publication-title: Horm. Res.
– volume: 92
  start-page: 137
  year: 2007
  end-page: 42
  article-title: Aldosterone‐to‐renin ratio as a marker for disease severity in 21‐hydroxylase deficiency congenital adrenal hyperplasia
  publication-title: J. Clin. Endocrinol. Metab.
– volume: 87
  start-page: 4106
  year: 2002
  end-page: 10
  article-title: High reliability of neonatal screening for congenital adrenal hyperplasia in Switzerland
  publication-title: J. Clin. Endocrinol. Metab.
– volume: 153
  start-page: 1272
  year: 1999
  end-page: 8
  article-title: Effect of newborn screening for congenital adrenal hyperplasia
  publication-title: Arch. Pediatr. Adolesc. Med.
– volume: 98
  start-page: 362
  year: 1996
  end-page: 7
  article-title: Congenital adrenal hyperplasia: neonatal mass screening compared with clinical diagnosis only in the Emilia‐Romagna region of Italy, 1980–1995
  publication-title: Pediatrics
– volume: 108
  start-page: 1320
  year: 2001
  end-page: 4
  article-title: Newborn screening for congenital adrenal hyperplasia in the Netherlands
  publication-title: Pediatrics
– volume: 67
  start-page: 284
  year: 2007
  end-page: 91
  article-title: How many deaths can be prevented by newborn screening for congenital adrenal hyperplasia?
  publication-title: Horm. Res.
– volume: 109
  start-page: 148
  year: 2010
  end-page: 55
  article-title: Clinical characteristics of Taiwanese children with congenital adrenal hyperplasia caused by 21‐hydroxylase deficiency in the pre‐screening era
  publication-title: J. Formos. Med. Assoc.
– volume: 126
  start-page: 118
  year: 1995
  end-page: 21
  article-title: Newborn screening for congenital adrenal hyperplasia in New Zealand
  publication-title: J. Pediatr.
– volume: 63
  start-page: 22
  year: 2005
  end-page: 8
  article-title: Female preponderance in congenital adrenal hyperplasia due to CYP21 deficiency in England: implications for neonatal screening
  publication-title: Horm. Res.
– volume: 39
  start-page: 1129
  year: 2003
  end-page: 40
  article-title: Lack of impact of platinum dose intensity on the outcome of ovarian cancer patients. 10‐year results of a prospective randomised phase III study comparing carboplatin‐cisplatin with cyclophosphamide‐cisplatin
  publication-title: Eur. J. Cancer
– volume: 70
  start-page: 214
  year: 1994
  end-page: 18
  article-title: Presentation, acute illness, and learning difficulties in salt wasting 21‐hydroxylase deficiency
  publication-title: Arch. Dis. Child.
– volume: 43
  start-page: 419
  year: 2006
  end-page: 23
  article-title: Audit of care of patients with congenital adrenal hyperplasia due to 21‐Hydroxylase deficiency in a referral hospital in South India
  publication-title: Indian Pediatr.
– volume: 6
  start-page: 306
  year: 1991
  end-page: 12
  article-title: Learning disabilities in children with congenital adrenal hyperplasia
  publication-title: J. Child Neurol.
– volume: 8
  start-page: 397
  year: 2005
  end-page: 401
  article-title: Autopsy diagnosis of 21‐hydroxylase deficiency CAH in a case of apparent SIDS
  publication-title: Pediatr. Dev. Pathol.
– volume: 86
  start-page: 2958
  year: 2001
  end-page: 64
  article-title: Lessons from 30 years of clinical diagnosis and treatment of congenital adrenal hyperplasia in five middle European countries
  publication-title: J. Clin. Endocrinol. Metab.
– volume: 55
  start-page: 110
  year: 2006
  end-page: 12
  article-title: Congenital adrenal hyperplasia in the Bahamas due to 21‐hydroxylase deficiency
  publication-title: West Indian Med. J.
– volume: 68
  start-page: 90
  issue: 5
  year: 2007
  end-page: 2
  article-title: Prenatal and neonatal diagnosis and treatment of congenital adrenal hyperplasia
  publication-title: Horm. Res.
– volume: 78
  start-page: 241
  year: 1994
  end-page: 6
  article-title: Clinical review 54: genetics, diagnosis, and management of 21‐hydroxylase deficiency
  publication-title: J. Clin. Endocrinol. Metab.
– volume: 13
  start-page: 5
  year: 1958
  end-page: 14
  article-title: [Perfect male external genital development and salt‐loss syndrome in girls with congenital adrenogenital syndrome.]
  publication-title: Helv. Paediatr. Acta
– volume: 101
  start-page: E11
  year: 1998
  article-title: Benefits of neonatal screening for congenital adrenal hyperplasia (21‐hydroxylase deficiency) in Sweden
  publication-title: Pediatrics
– volume: 44
  start-page: 554
  year: 2008
  end-page: 9
  article-title: Two‐year pilot study of newborn screening for congenital adrenal hyperplasia in New South Wales compared with nationwide case surveillance in Australia
  publication-title: J. Paediatr. Child Health
– volume: 101
  start-page: 583
  year: 1998
  end-page: 90
  article-title: Results of screening 1.9 million Texas newborns for 21‐hydroxylase‐deficient congenital adrenal hyperplasia
  publication-title: Pediatrics
– volume: 22
  start-page: 127
  year: 2009
  end-page: 41
  article-title: 21‐hydroxylase genotyping in Australasian patients with congenital adrenal hyperplasia
  publication-title: J. Pediatr. Endocrinol.
– volume: 166
  start-page: 1
  year: 2007
  end-page: 4
  article-title: Prevalence of congenital adrenal hyperplasia among sudden infant death in the Czech Republic and Austria
  publication-title: Eur. J. Pediatr.
– ident: e_1_2_5_24_2
  doi: 10.1001/archpedi.153.12.1272
– ident: e_1_2_5_8_2
  doi: 10.1542/peds.108.6.1320
– ident: e_1_2_5_15_2
  doi: 10.1007/s00431-003-1311-y
– ident: e_1_2_5_19_2
  doi: 10.1007/s10024-005-0004-0
– ident: e_1_2_5_5_2
  doi: 10.1542/peds.101.4.583
– ident: e_1_2_5_18_2
  doi: 10.1542/peds.101.4.e11
– ident: e_1_2_5_20_2
  doi: 10.1159/000098400
– ident: e_1_2_5_11_2
  doi: 10.1111/j.1440-1754.2008.01383.x
– volume: 81
  start-page: 866
  year: 1988
  ident: e_1_2_5_3_2
  article-title: Worldwide experience in newborn screening for classical congenital adrenal hyperplasia due to 21‐hydroxylase deficiency
  publication-title: Pediatrics
  contributor:
    fullname: Pang SY
– ident: e_1_2_5_9_2
  doi: 10.1007/s00431-006-0154-8
– ident: e_1_2_5_27_2
  doi: 10.1210/jc.78.2.241
– ident: e_1_2_5_28_2
  doi: 10.1136/adc.70.3.214
– ident: e_1_2_5_10_2
  doi: 10.1515/JPEM.2008.21.5.455
– ident: e_1_2_5_22_2
  doi: 10.1016/S0022-3476(95)70513-9
– ident: e_1_2_5_23_2
  doi: 10.1159/000113023
– ident: e_1_2_5_7_2
  doi: 10.1515/JPEM.2009.22.2.127
– ident: e_1_2_5_2_2
  doi: 10.1016/S0959-8049(03)00152-7
– ident: e_1_2_5_6_2
  doi: 10.1210/jc.2006-0964
– volume: 98
  start-page: 362
  year: 1996
  ident: e_1_2_5_4_2
  article-title: Congenital adrenal hyperplasia: neonatal mass screening compared with clinical diagnosis only in the Emilia‐Romagna region of Italy, 1980–1995
  publication-title: Pediatrics
  contributor:
    fullname: Balsamo A
– volume: 43
  start-page: 419
  year: 2006
  ident: e_1_2_5_14_2
  article-title: Audit of care of patients with congenital adrenal hyperplasia due to 21‐Hydroxylase deficiency in a referral hospital in South India
  publication-title: Indian Pediatr.
  contributor:
    fullname: Bhaskaran S
– volume: 13
  start-page: 5
  year: 1958
  ident: e_1_2_5_12_2
  article-title: [Perfect male external genital development and salt‐loss syndrome in girls with congenital adrenogenital syndrome.]
  publication-title: Helv. Paediatr. Acta
  contributor:
    fullname: Prader A
– ident: e_1_2_5_26_2
  doi: 10.1210/jc.2002-012093
– ident: e_1_2_5_25_2
  doi: 10.1210/jc.86.7.2958
– ident: e_1_2_5_29_2
  doi: 10.1177/088307389100600404
– ident: e_1_2_5_17_2
  doi: 10.1016/S0929-6646(10)60035-6
– ident: e_1_2_5_13_2
  doi: 10.1159/000082896
– ident: e_1_2_5_21_2
  doi: 10.1159/000110586
– ident: e_1_2_5_16_2
  doi: 10.1590/S0043-31442006000200009
SSID ssj0002558
Score 2.1097498
Snippet Aim:  To evaluate the incidence, sex distribution, ethnicity, age at diagnosis, clinical presentation and morbidity of all childhood‐onset congenital adrenal...
To evaluate the incidence, sex distribution, ethnicity, age at diagnosis, clinical presentation and morbidity of all childhood-onset congenital adrenal...
Aim:  To evaluate the incidence, sex distribution, ethnicity, age at diagnosis, clinical presentation and morbidity of all childhood‐onset congenital adrenal...
Aim: To evaluate the incidence, sex distribution, ethnicity, age at diagnosis, clinical presentation and morbidity of all childhood-onset congenital adrenal...
AIMTo evaluate the incidence, sex distribution, ethnicity, age at diagnosis, clinical presentation and morbidity of all childhood-onset congenital adrenal...
SourceID proquest
crossref
pubmed
wiley
istex
SourceType Aggregation Database
Index Database
Publisher
StartPage 1029
SubjectTerms Adolescent
Adrenal glands
Adrenal Hyperplasia, Congenital - epidemiology
Adrenal Hyperplasia, Congenital - ethnology
Adrenal Hyperplasia, Congenital - physiopathology
Child
Child, Preschool
Confidence Intervals
congenital adrenal hyperplasia
Congenital diseases
Ethnicity
Female
Gender
Humans
Incidence
Male
newborn screening
Oceanic Ancestry Group
Retrospective Studies
Sex Distribution
Western Australia
Western Australia - epidemiology
Young Adult
Title Ethnic and gender differences in rates of congenital adrenal hyperplasia in Western Australia over a 21 year period
URI https://api.istex.fr/ark:/67375/WNG-STW9HB5K-9/fulltext.pdf
https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fj.1440-1754.2012.02584.x
https://www.ncbi.nlm.nih.gov/pubmed/23039988
https://www.proquest.com/docview/1132869430/abstract/
https://search.proquest.com/docview/1141538526
Volume 48
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3dT9swED9NRZp4YWzjI6NMnjTxliofzkcfoYJVTEMIWrVvlh3bgCqlqB8S8Ndz56QZRTxMaC9JlDhf5zv7d_bdzwA_Ex0obSPuy8hyn2sufdlNYj-2iVUKa1xV0RYXaX_Iz8fJuI5_olyYih-iGXAjy3DtNRm4VPNXRk7zkpkbGqEhvQg70w7hSeLVI3x09ZdJCpFznRWHX5SHwXpQz5sPWuupNkjoD2_B0HVU67qls08wWf1QFY0y6SwXqlM8veJ6_D9_vA1bNXplx5W6fYYPpvwCH__U8_NfYX66uC3vCiZLzW7cInVstQILtkfsrmTETDFnU8vQD8cStGQJk5RNjvtb9Iln9y6vk4qOKhIH1gzHMAo3ZZJFIXtEA2VE0jzVOzA8Ox30-n69rINfcERfPo9lmOlA5xpbC25DGyiERcqkqohiI4kgMDHWoN-ImhKkikjqJNHyZ2mo0UONd6FVTkuzDywwCq3c4lYanqE0pMyKLjpdqGUa3-FBuKpCcV-xd4iXXg_HY5SmIGkKJ03x4MGRq-vmBjmbUPRblojRxS9xPRh1-yfJb9H1oL1SBlEb_hwfHUd5Spz2HvxoLqPJ0jyMLM10SWU49TNJlHqwVylR8zL0CBEy5rkHqVOFf_5scX7Zo6Nv773xADbpdJVn2YbWYrY0hwi4Fuq7M6VnPJoZrw
link.rule.ids 315,786,790,1382,27957,27958,46329,46753
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LT9wwEB5VILW9lD5pgLZGqnrLKg87yR4BQZfXCtFFy82yY7sgqizahwT8emacbMoiDlXFJYkUJ07GM_bMeOYbgO_CRNq4hIcqcTzkhqtQdUUapk44rXHEdR1t0c96Z_zgXJw35YAoF6bGh2gdbiQZfr4mASeH9CMpp43J3PtGyKeX4GraQYVyGaVfePvq9C-WFOrOTV4cflMRR4thPU--aWGtWiay3zyliC7qtX5h2luBP_NfquNRrjqzqe6Ud4_QHp_pn9_Cm0aBZVs1x72DF7Z6Dy-Pmy36DzDZnV5UlyVTlWG_fZ06Ni_CglMSu6wYgVNM2MgxNMWxBVUtYYoSyvF8gWbx-NqndlLTYY3jwFqPDKOIU6ZYErNblFFGOM0j8xHO9nYHO72wqewQlhwVsJCnKs5NZAqDEwZ3sYs0akbaZrpMUqsII1BYZ9F0RGaJMk04dYqQ-fMsNmikpp9gqRpV9jOwyGoUdIdHZXmO1FAqL7todyGjGewjgHg-hvK6BvCQDw0fjtdITUnUlJ6a8iaAH36w2wfU-IoC4HIhh_2f8tdg2O1ti0PZDWBjzg2ykf0JvjpNioxg7QPYbG-j1NJWjKrsaEZtOC01IskCWK25qO0MjULUGosigMzzwj9_tjw42aGrtf998Bu86g2Oj-TRfv9wHV5TkzrtcgOWpuOZ_YL611R_9XJ1D_z0HdE
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3dT9swED9NVEK8sC8G2TrmSYi3VPlwPvq4AV2BrUJ8qLxZdmyvqFJa9UNi--t356SBIh6maS9JpDhxcr6zf2ff_QxwkOhAaRtxX0aW-1xz6ctuEvuxTaxS2OKqirYYpP0bfnab3NbxT5QLU_FDNBNuZBmuvyYDn2r7xMhpXTJzUyM0pRfhYNpBPNniaRyRhh9fPlBJIXSu0-Lwk_IwWI_qefZNa0NVi6R-_xwOXYe1blzqvYTx6o-qcJRxZ7lQneL3E7LH__PLr2C7hq_sS6Vvr-GFKd_A5o96gf4tzE8Wo_KuYLLU7KfbpY6ttmDBDondlYyoKeZsYhk64liC9ixhktLJ8TxCp3g2dYmdVHRYsTiwZj6GUbwpkywK2S-0UEYszRO9Aze9k-ujvl_v6-AXHOGXz2MZZjrQucbugtvQBgpxkTKpKqLYSGIITIw16DiiqgSpIpY6Sbz8WRpqdFHjd7BRTkqzBywwCs3c4lEanqE0pMyKLnpdqGYa6_AgXDWhmFb0HeKx28PxGqUpSJrCSVPce3Do2rp5QM7GFP6WJWI4-Caurofd_tfkXHQ9aK-UQdSWP8dXx1GeEqm9B5-b22iztBAjSzNZUhlOA00SpR7sVkrUVIYuIWLGPPcgdarw158tzi6O6Or9vz74CTYvjnvi--ng_ANsUYkq57ING4vZ0nxE8LVQ-86q_gB0IxyA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Ethnic+and+gender+differences+in+rates+of+congenital+adrenal+hyperplasia+in+Western+Australia+over+a+21+year+period&rft.jtitle=Journal+of+paediatrics+and+child+health&rft.au=Shetty%2C+Vinutha+B&rft.au=Bower%2C+Carol&rft.au=Jones%2C+Timothy+W&rft.au=Lewis%2C+Barry+D&rft.date=2012-11-01&rft.pub=Blackwell+Publishing+Ltd&rft.issn=1034-4810&rft.eissn=1440-1754&rft.volume=48&rft.issue=11&rft.spage=1029&rft_id=info:doi/10.1111%2Fj.1440-1754.2012.02584.x&rft.externalDBID=NO_FULL_TEXT&rft.externalDocID=2807544041
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1034-4810&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1034-4810&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1034-4810&client=summon